NCT01836276View on ClinicalTrials.gov

Understanding Disparities in Quitting in African American and White Smokers

PHASE4CompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline

1 mg of varenicline twice daily after titration to full strength in the first week following standard dosing guidelines

Trial Locations (2)

64130

Swope Health Central, Kansas City

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Pfizer

INDUSTRY

lead

Nikki Nollen, PhD, MA

OTHER

NCT01836276 - Understanding Disparities in Quitting in African American and White Smokers | Biotech Hunter | Biotech Hunter